Orchard Looks toward Harvesting Expanded Gene Therapy Pipeline

18:18
 
Share
 

Manage episode 227325747 series 60790
By Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio streamed directly from their servers.
It was about ten months ago that Orchard Therapeutics acquired the gene therapy portfolio of GSK, expanding its pipeline and giving it its first approved therapy. We spoke to Orchard CEO Mark Rothera about his company’s approach to gene therapy, its pipeline, and what he sees as the biggest challenges as Orchard moves towards commercializing its therapies.

239 episodes available. A new episode about every 6 days averaging 23 mins duration .